According to the Zhitong Finance App, Wohua Pharmaceutical (002107.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 589 million yuan, a year-on-year decrease of 5.73%. Net profit attributable to shareholders of listed companies was 92.6545 million yuan, an increase of 44.78% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 90.659 million, an increase of 47.94% over the previous year.

According to the Zhitong Finance App, Wohua Pharmaceutical (002107.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 589 million yuan, a year-on-year decrease of 5.73%. Net profit attributable to shareholders of listed companies was 92.6545 million yuan, an increase of 44.78% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 90.659 million, an increase of 47.94% over the previous year.